Two faculty members from the U of T Institute of Biomaterials & Biomedical Engineering (IBBME) have earned support from the latest round of Canada Research Chairs (CRC) program announcements.
Professor Rodrigo Fernandez-Gonzalez has been named the Canada Research Chair in Quantitative Cell Biology and Morphogenesis while Professor Milica Radisic‘s CRC in Functional Cardiovascular Tissue Engineering has been renewed.
Launched in 2000, the Canada Research Chair program aims to help the country attract and retain research leaders in engineering and natural sciences, health sciences, humanities and social sciences.
Rodrigo Fernandez-Gonzalez, Assistant Professor & Canada Research Chair in Quantitative Cell Biology and Morphogenesis
Radisic and her team create sophisticated systems for growing human cells outside the body.
Their lab-grown constructs include heart tissues that beat realistically and liver tissue that can metabolize certain drugs.
Through the spinoff company TARA Biosystems, Radisic’s creations are already being used to test new drugs for potentially dangerous side effects.
In the future, they could be implanted back into the body to repair organs damaged by disease or injury.
“The University of Toronto is proud of the tremendous globally important research our 15 new and 13 renewed Canada Research Chairs are involved in,” said Vivek Goel, U of T’s vice-president of research and innovation. “We also appreciate the ongoing support of the Government of Canada in funding this research, which enables U of T to attract and retain some of the top scholars in the world.”
This is the third CRC appointment for IBBME in the 2016-2017 academic year. In December, Professor Penney Gilbert was named the CRC in Endogenous Repair. Her research focuses on deciphering cues that could “wake up” muscle stem cells to inform the development of new drugs, therapies and treatments that restore strength to muscles that are wasting as a result of aging or disease.